CLINICAL AND EXPERIMENTAL NEPHROLOGY, vol.25, no.5, pp.488-500, 2021 (SCI-Expanded)
Background The aim of this study was to define the clinicopathologic features of phospholipase A(2) receptor (PLA(2)R) and/or thrombospondin type-1 domain-containing 7A (THSD7A) associated membranous nephropathy(MN) focusing on their impact to disease relapse and response to treatment.